A statement released today by Hauck & Aufhäuser Privatbankiers KGaA about Gerresheimer (ETR:GXI) raises the target price to 80.00EUR
- Updated: October 4, 2016
Having a price of 76.14EUR, Gerresheimer (ETR:GXI) traded 0.00% even on the day. With the last stock price up 0.00% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. The company has recorded a 50-day moving average of 0.00EUR and a 200-day moving average of 0.00EUR. 0 shares of the stock were exchanged, down from an average trading volume of 0
In a report issued 10/05/2016 Hauck & Aufhäuser Privatbankiers KGaA bumped up the target of Gerresheimer (ETR:GXI) to 80.00EUR stating a potential upside of 0.05%.
On Tuesday October 04, 2016, Hauck & Aufhäuser Privatbankiers KGaA released a statement about Gerresheimer (ETR:GXI) upped the target price from 0.00EUR to 80.00EUR that suggested an upside of 0.05%.
See Chart Below
Gerresheimer has a 52 week low of 0.00EUR and a 52 week high of 0.00EUR The company’s market cap is currently 0 EUR.
General Information About Gerresheimer (ETR:GXI)
Gerresheimer AG is a Germany-based company that operates in the pharmaceuticals and health care industry. It is structured in three business segments: Plastic and Devices, Primary Packaging Glass and Life Science Research. The Company produces pharmaceutical packaging products, as well as drug-delivery systems made out of glass and plastics or a combination of both. Its product portfolio includes insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.